Premature Ejaculation Treatment Market Explore Future Growth To 2026 Anticipated by Global Top Players - Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScie

Ejaculation means discharging of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified into two types, namely lifelong (primary) PE and acquired (secondary) PE.

Lifelong (primary) PE is a condition, which affects a male lifelong, nearly from the beginning of his first sexual encounter. Acquired (secondary) PE is a condition in which a male who has a normal sex life starts suffering from PE. The actual cause of PE is not known, however, it can be caused due to some psychological and biological factors such as early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1956

Market Dynamics -

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to raise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive the growth of the market

Key players in the market are focusing on launching new products, which in turn is expected to aid in the growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received the patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel the growth of the global premature ejaculation treatment market in the near future.

The global premature ejaculation treatment market size was valued at US$ 1.5 Bn in 2017 and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).

Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1956

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :
Selective Serotonin Reuptake Inhibitors (SSRIs)
- Dapoxetine
- Others
Phosphodiesterase Type 5 (PDE5) Inhibitors
- Zertane
- Others
Topical Anesthetics
Others

Global Premature Ejaculation Treatment Market, By Route of Administration:
Oral
Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:
Pills
Spray
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.